Portfolio company
Nostos Genomics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops an automated software platform for variant interpretation that helps genetic testing laboratories diagnose patients with rare diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Nostos
Nostos Genomics develops an artificial intelligence platform to provide genetic variant interpretation and disease diagnosis for medical testing laboratories.
Lucid Genomics
This company develops an artificial intelligence platform for long-read genomic data interpretation to assist clinical laboratories and pharmaceutical researchers with diagnostics.
Genorare
This company develops an encrypted artificial intelligence platform for hospitals and pharmaceutical firms to diagnose rare diseases using genomic and electronic health record data.
3X Genetics
This company develops long-read genetic testing technology and diagnostics for biopharma companies to identify patients with rare repeat expansion disorders.
Fabric Genomics
This company provides a clinical software platform for genomic data interpretation and reporting to diagnostic laboratories and hospital systems.
TMA Precision Health
This company provides a clinical decision support platform using genomic data and medical records to improve rare disease diagnosis for health systems and pharmaceutical partners.
Noscendo
This company develops bioinformatic software and diagnostic platforms to identify pathogens in bloodstream infections for hospitals and clinical laboratories.
FDNA
This company develops artificial intelligence phenotyping software to help clinicians and researchers identify rare diseases and genetic disorders in patients.
